Trials / Completed
CompletedNCT06732635
Enhanced Recovery After Surgery (ERAS) for Laparoscopic Hysterectomy at Low Risk Endometrial Cancer
Enhanced Recovery After Surgery (ERAS) for Laparoscopic Hysterectomy at Low Risk Endometrial Cancer: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Enhanced recovery after surgery (ERAS) programs are designed to achieve early recovery after surgery and a shorter length of stay (LOS) at hospital. So far there are only three prospective, randomised studies that exclusively analyze patients affected by oncogynecological pathology providing a high level of scientific evidence. To our knowledge, no studies have been conducted specifically on ERAS pathways in endometrial cancer treated by laparoscopy. This study aims to evaluate whether ERAS pathways are beneficial for patients with endometrial cancer, particularly among low-risk early endometrial cancer operated by laparoscopy. Length of stay (LOS), perioperative morbidity and mortality, and perioperative quality of life were analyzed comparing both ERAS and Conventional protocols groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Enhanced recovery after surgery (ERAS) | Enhanced recovery after surgery (ERAS) programs are designed to achieve early recovery after surgery and a shorter length of stay (LOS) at hospital. |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2022-01-01
- Completion
- 2022-03-01
- First posted
- 2024-12-13
- Last updated
- 2024-12-13
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06732635. Inclusion in this directory is not an endorsement.